B

BridgeBio Oncology Therapeutics Inc
D

BBOT

11.310
USD
0.44
(4.05%)
مفتوح الان
حجم التداول
1,830
الربح لكل سهم
-53
العائد الربحي
-
P/E
-10
حجم السوق
895,714,790
المقالات

العنوان: BridgeBio Oncology Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.